Department of Biochemistry and Biophysics, Department of Cancer Biology and Penn Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.
Cell. 2022 Jun 23;185(13):2203-2205. doi: 10.1016/j.cell.2022.05.026.
Targeted protein degradation has emerged as a powerful tool for therapeutic development and biological exploration. In this issue of Cell, Morreale et al. report the development of the BacPROTAC technology to enable targeted protein degradation in Gram-positive bacteria and mycobacteria via reprogramming of Clp proteases.
靶向蛋白降解已成为治疗开发和生物探索的有力工具。在本期《细胞》杂志上,Morreale 等人报告了 BacPROTAC 技术的发展,该技术通过重新编程 Clp 蛋白酶,可实现革兰氏阳性菌和分枝杆菌中的靶向蛋白降解。